Tuesday, February 3, 2015

Accel Diagnostics is the Winner of PMWC 2015 Silicon Valley Emerging Company Competition in the Rx/Dx Category

February 3, 2015, Pittsburgh, PA — Accel Diagnostics (AccelDx) the leader developer of mobileenabled blood diagnostic tests was the winner of the PMWC 2015 Silicon Valley emerging company competition in the Rx/Dx Category. AccelDx technology screens biomarkers associated with lifethreatening medical conditions such as congestive heart failure (CHF). The technology enables patients to self-test and monitor chronic illnesses in the comfort of the patient's home or at the doctor’s office.

The PMWC Most Promising Company Competition started at the first PMWC 2010 and most companies have already reached that next stage of the IPO or the acquisition.

“We take winning the PMWC emerging company competition as a strong recognition of our work and encouragement to continue our mission to provide every patient the right tool to live a better, healthier and comfortable life.”

Accel Diagnostics is a Pittsburgh, PA, based company with an office in Berkeley, CA, developing mobile-enabled blood screening technology for disease specific biomarkers that enable patient selftesting, anytime-anywhere, and physician remote monitoring. For more information on AccelDx, please email info@acceldx.com or visit http://www.acceldx.com

About PMWC Interactive

The Personalized Medicine World Conference (PMWC) is an independent and established conference that attracts recognized authorities and experts across healthcare and biotechnology sectors. The Conference showcases practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional collaboration to further adoption of personalized medicine in the clinic.

PMWC 2015 is produced by Silicon Ventures and Co-host by Oracle Health Sciences and Stanford Health Care.

By: Alberto Gandini, Accel Diagnostics